Two General Methods for Population Pharmacokinetic Modeling: Non-Parametric Adaptive Grid and Non-Parametric Bayesian
Tatiana Tatarinova, Michael Neely, Jay Bartroff, Michael van Guilder,, Walter Yamada, David Bayard, Roger Jelliffe, Robert Leary, Alyona Chubatiuk, and Alan Schumitzky

TL;DR
This paper compares two nonparametric methods, NPAG and NPB, for population pharmacokinetic modeling, demonstrating their effectiveness in realistic simulated datasets with practical challenges.
Contribution
It introduces and evaluates two novel nonparametric algorithms, NPAG and NPB, for estimating population PK/PD distributions, highlighting their performance and advantages.
Findings
Both methods showed excellent performance in simulated PK studies.
They effectively handle unbalanced data and covariates like patient weight.
The algorithms are implemented in R and freely available.
Abstract
Population pharmacokinetic (PK) modeling methods can be statistically classified as either parametric or nonparametric (NP). Each classification can be divided into maximum likelihood (ML) or Bayesian (B) approaches. In this paper we discuss the nonparametric case using both maximum likelihood and Bayesian approaches. We present two nonparametric methods for estimating the unknown joint population distribution of model parameter values in a pharmacokinetic/pharmacodynamic (PK/PD) dataset. The first method is the NP Adaptive Grid (NPAG). The second is the NP Bayesian (NPB) algorithm with a stick-breaking process to construct a Dirichlet prior. Our objective is to compare the performance of these two methods using a simulated PK/PD dataset. Our results showed excellent performance of NPAG and NPB in a realistically simulated PK study. This simulation allowed us to have benchmarks in the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
